Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 1/20 | 0.31 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | LPL | P06858 | 1/20 | 0.30 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18034448 | 0.89 | MEN1 (0.33) | PRMT5WDR77MEN1POLBMAPT | |
| SCHEMBL18034407 | 0.89 | MEN1 (0.33) | PRMT5WDR77MEN1POLBMAPT | |
| SCHEMBL18034401 | 0.89 | MEN1 (0.33) | PRMT5WDR77MEN1POLBMAPT | |
| SCHEMBL20224582 | 0.89 | MEN1 (0.32) | PRMT5WDR77MEN1POLBMAPT | |
| SCHEMBL19862392 | 0.87 | PRMT5 (0.33) | PRMT5WDR77LPLLIPG | |
| SCHEMBL19862389 | 0.83 | PRMT5 (0.32) | PRMT5WDR77LPLLIPG | |
| SCHEMBL19862383 | 0.83 | PRMT5 (0.32) | PRMT5WDR77LPLLIPG | |
| SCHEMBL19869597 | 0.82 | LPL (0.39) | PRMT5WDR77LPLLIPG | |
| SCHEMBL19863938 | 0.81 | LPL (0.42) | PRMT5WDR77LPLLIPG | |
| SCHEMBL18034437 | 0.80 | HIF1A (0.33) | MEN1POLBMAPTDUSP3BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10454039-B2 | Compound and organic electronic device using the same | SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) | 2019-10-22 | — | — | US | disclosed |
| US-20180047918-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-02-15 | — | — | US | disclosed |
| US-20180047918-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | NICHEM FINE TECHNOLOGY CO., LTD. (TW) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180047918-A1 | COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME | ORC3, AOX1, RCOR3 | PRMT5 1822/4885WDR77 1593/4885MEN1 2797/4885 |
| US-10454039-B2 | Compound and organic electronic device using the same | ORC3, AOX1, RCOR3 | PRMT5 1822/4885WDR77 1593/4885MEN1 2797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.